These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17504377)

  • 1. Magnetic resonance imaging appearances of recurrent cervical carcinoma.
    Babar S; Rockall A; Goode A; Shepherd J; Reznek R
    Int J Gynecol Cancer; 2007; 17(3):637-45. PubMed ID: 17504377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical carcinoma with full-thickness stromal invasion: efficacy of dynamic MR imaging in the assessment of parametrial involvement.
    Iwata S; Joja I; Okuno K; Miyagi Y; Sakaguchi Y; Kudo T; Hiraki Y
    Radiat Med; 2002; 20(5):247-55. PubMed ID: 12450104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer.
    Kim JY; Byun SJ; Kim YS; Nam JH
    Gynecol Oncol; 2017 Jan; 144(1):34-39. PubMed ID: 27789082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience.
    Sahdev A; Sohaib SA; Wenaden AE; Shepherd JH; Reznek RH
    Int J Gynecol Cancer; 2007; 17(3):629-36. PubMed ID: 17309561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Completion surgery after chemoradiotherapy for cervical cancer - is there a role? UK Cancer Centre experience of hysterectomy post chemo-radiotherapy treatment for cervical cancer.
    Platt SL; Patel A; Humphrey PJ; Al-Booz H; Bailey J
    J Obstet Gynaecol; 2019 Jan; 39(1):68-73. PubMed ID: 30230397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of MRI in the management and staging of cancer of the uterine cervix.
    Stenstedt K; Hellström AC; Fridsten S; Blomqvist L
    Acta Oncol; 2011 Apr; 50(3):420-6. PubMed ID: 21166605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery.
    Gui B; Valentini AL; Miccò M; D'Agostino GR; Tagliaferri L; Zannoni GF; Fanfani F; Manfredi R; Bonomo L
    Acta Radiol; 2016 Sep; 57(9):1123-31. PubMed ID: 26622060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
    Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
    Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance in the evaluation of parametrial involvement in carcinoma of the cervix uteri].
    Fischetti SG; Coppolino F; Priolo GD; Chiarenza R; Garufi A; Privitera G; Materazzo S; Loreto C
    Radiol Med; 1991 Oct; 82(4):470-9. PubMed ID: 1767055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent uterine cervical carcinoma: spectrum of imaging findings.
    Choi JI; Kim SH; Seong CK; Sim JS; Lee HJ; Do KH
    Korean J Radiol; 2000; 1(4):198-207. PubMed ID: 11752955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
    Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z
    Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uterine cervical cancer: usefulness of MR imaging after the initial radiation therapy].
    Monzen Y; Mori H; Matsumoto A; Yoshida S; Wakisaka M; Komatsu E; Tashiro M; Hori Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Sep; 55(11):745-50. PubMed ID: 8532506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
    Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
    Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of diffusion-weighted MRI in diagnosis of uterine cervical cancer: a prospective study evaluating the benefits of DWI compared to conventional MR sequences in a 3T environment.
    Exner M; Kühn A; Stumpp P; Höckel M; Horn LC; Kahn T; Brandmaier P
    Acta Radiol; 2016 Jul; 57(7):869-77. PubMed ID: 26329683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The negative predictive value of clinical examination with or without anesthesia versus magnetic resonance imaging for parametrial infiltration in cervical cancer stages IB1 to IIA.
    Bleker SM; Bipat S; Spijkerboer AM; van der Velden J; Stoker J; Kenter GG
    Int J Gynecol Cancer; 2013 Jan; 23(1):193-8. PubMed ID: 23221736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients.
    Yang K; Park W; Huh SJ; Park BK; Kim CK; Kim BG; Bae DS; Lee JW
    Int J Gynecol Cancer; 2017 Mar; 27(3):507-513. PubMed ID: 28129242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy.
    Schmid MP; Fidarova E; Pötter R; Petric P; Bauer V; Woehs V; Georg P; Kirchheiner K; Berger D; Kirisits C; Dörr W; Dimopoulos JC
    Acta Oncol; 2013 Oct; 52(7):1384-90. PubMed ID: 23957566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent cervical carcinoma: typical and atypical manifestations.
    Fulcher AS; O'Sullivan SG; Segreti EM; Kavanagh BD
    Radiographics; 1999 Oct; 19 Spec No():S103-16; quiz S264-5. PubMed ID: 10517448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
    Onal C; Erbay G; Guler OC
    J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.